PUBLICATION
METTL3-dependent m6A modification of PSEN1 mRNA regulates craniofacial development through the Wnt/β-catenin signaling pathway
- Authors
- Ma, L., Zhou, X., Yao, S., Zhang, X., Mao, J., Vona, B., Fan, L., Lou, S., Li, D., Wang, L., Pan, Y.
- ID
- ZDB-PUB-240321-10
- Date
- 2024
- Source
- Cell Death & Disease 15: 229229 (Journal)
- Registered Authors
- Keywords
- none
- MeSH Terms
-
- Animals
- Methylation
- Methyltransferases/genetics
- Methyltransferases/metabolism
- Presenilin-1/genetics
- Presenilin-1/metabolism
- RNA, Messenger/genetics
- RNA, Messenger/metabolism
- Wnt Signaling Pathway*/genetics
- Zebrafish/genetics
- Zebrafish/metabolism
- Zebrafish Proteins/genetics
- Zebrafish Proteins/metabolism
- beta Catenin*/genetics
- beta Catenin*/metabolism
- PubMed
- 38509077 Full text @ Cell Death Dis.
Citation
Ma, L., Zhou, X., Yao, S., Zhang, X., Mao, J., Vona, B., Fan, L., Lou, S., Li, D., Wang, L., Pan, Y. (2024) METTL3-dependent m6A modification of PSEN1 mRNA regulates craniofacial development through the Wnt/β-catenin signaling pathway. Cell Death & Disease. 15:229229.
Abstract
Craniofacial malformations, often associated with syndromes, are prevalent birth defects. Emerging evidence underscores the importance of m6A modifications in various bioprocesses such as stem cell differentiation, tissue development, and tumorigenesis. Here, in vivo, experiments with zebrafish models revealed that mettl3-knockdown embryos at 144 h postfertilization exhibited aberrant craniofacial features, including altered mouth opening, jaw dimensions, ethmoid plate, tooth formation and hypoactive behavior. Similarly, low METTL3 expression inhibited the proliferation and migration of BMSCs, HEPM cells, and DPSCs. Loss of METTL3 led to reduced mRNA m6A methylation and PSEN1 expression, impacting craniofacial phenotypes. Co-injection of mettl3 or psen1 mRNA rescued the level of Sox10 fusion protein, promoted voluntary movement, and mitigated abnormal craniofacial phenotypes induced by mettl3 knockdown in zebrafish. Mechanistically, YTHDF1 enhanced the mRNA stability of m6A-modified PSEN1, while decreased METTL3-mediated m6A methylation hindered β-catenin binding to PSEN1, suppressing Wnt/β-catenin signaling. Pharmacological activation of the Wnt/β-catenin pathway partially alleviated the phenotypes of mettl3 morphant and reversed the decreases in cell proliferation and migration induced by METTL3 silencing. This study elucidates the pivotal role of METTL3 in craniofacial development via the METTL3/YTHDF1/PSEN1/β-catenin signaling axis.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping